Semaglutide associated with vision loss in large observational study
A retrospective cohort study has linked semaglutide to double the risk of serious optic neuropathy in type 2 diabetes patients. Published in JAMA Ophthalmology, the…
Tag: Semaglutide
‘They are devastated’: When your patient discovers stopping semaglutide means the weight returns
Semaglutide is a game changer for patients right up until they stop the treatment, when many face the heartbreak of watching the kilos return. That…
Hundreds of doctors sent warnings for prescribing semaglutide on PBS to patients without diabetes
Health officials have started a mass letter mail-out to doctors they suspect are using the PBS to prescribe subsidised semaglutide to patients without diabetes. Without…
TGA approves Wegovy for reducing MACE risk
The TGA has approved Wegovy to reduce the risk of major adverse events in patients with cardiovascular disease who are overweight or obese. The once-weekly…
GLP-1 RAs linked to eye complications in JAMA case series
A case series has rekindled concerns about potential eye-related complications associated with semaglutide and tirzepatide. Published in JAMA Ophthalmology, it documents instances of serious ophthalmic…
